CDK19 and neoplasm: Similar to the in vitro molecular biomarkerdata, the tumor STAT1SER727 phosphorylation data indicatea partial redundancy between CDK8 and CDK19 loss, with CDK8 inhibitionplaying a greater role than CDK19 in the molecular response to CCT251921treatment in vivo.